# siRNA Therapeutics: From Bench Lab. to Clinics

**Authors:** Cristina Romero-López, Alfredo Berzal-Herranz

PMC · DOI: 10.3390/ph17040416 · Pharmaceuticals · 2024-03-26

## Full-text entities

- **Genes:** COL4A2 (collagen type IV alpha 2 chain) [NCBI Gene 1284] {aka BSVD2, BSVD2A, BSVD2B, ICH, POREN2}, CDC20 (cell division cycle 20) [NCBI Gene 991] {aka CDC20A, OOMD14, OZEMA14, bA276H19.3, p55CDC}, AQP3 (aquaporin 3 (Gill blood group)) [NCBI Gene 360] {aka AQP-3, GIL}, DROSHA (drosha ribonuclease III) [NCBI Gene 29102] {aka ETOHI2, HSA242976, RANSE3L, RN3, RNASE3L, RNASEN}, MIR34A (microRNA 34a) [NCBI Gene 407040] {aka MIRN34A, miRNA34A, mir-34, mir-34a}
- **Diseases:** gastric, hepatocellular, pancreatic and colorectal cancer (MESH:D015179), cirrhosis (MESH:D005355), liver fibrosis (MESH:D008103), gastro-intestinal tumors (MESH:D007414), metabolic or rare diseases (MESH:D035583), TNBC (MESH:D064726), hepatocellular carcinoma (MESH:D006528), erythroleukemia (MESH:D004915), cancer (MESH:D009369), metastasis (MESH:D009362), injury to people or property (MESH:C000719191), breast cancer (MESH:D001943), erythroid disorders (MESH:D029503), bone-related tumours (MESH:D001859), uterine leiomyoma (OMIM:150699), lung disease (MESH:D008171), gastrointestinal tumours (MESH:D005770), oncological (MESH:D000072716), chronic myeloid leukaemia (MESH:D015451), cytotoxicity (MESH:D064420), chondrosarcoma (MESH:D002813), osteosarcoma (MESH:D012516), pulmonary fibrosis (MESH:D011658)
- **Species:** Drosophila melanogaster (fruit fly, species) [taxon 7227], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11053421/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC11053421/full.md

---
Source: https://tomesphere.com/paper/PMC11053421